blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3267197

EP3267197 - METHOD AND KIT FOR THE DETECTION OF PANCREATIC DYSFUNCTION [Right-click to bookmark this link]
Former [2018/02]PANCREATIC DYSFUNCTION DETECTION METHOD AND DETECTION KIT
[2020/37]
StatusNo opposition filed within time limit
Status updated on  23.07.2021
Database last updated on 27.07.2024
FormerThe patent has been granted
Status updated on  14.08.2020
FormerGrant of patent is intended
Status updated on  06.04.2020
FormerExamination is in progress
Status updated on  11.10.2019
FormerRequest for examination was made
Status updated on  08.12.2017
FormerThe international publication has been made
Status updated on  19.09.2017
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): TR		published on 17.07.2024  [2024/29]
Applicant(s)For all designated states
Toray Industries, Inc.
1-1, Nihonbashi-Muromachi 2-chome Chuo-ku
Tokyo 103-8666 / JP
For all designated states
National Cancer Center
1-1, Tsukiji 5-Chome
Chuo-ku
Tokyo 104-0045 / JP
[2018/02]
Inventor(s)01 / KOBAYASHI Michimoto
c/o Basic Research Center
Toray Industries Inc.
10-1
Tebiro 6-chome
Kamakura-shi Kanagawa 248-8555 / JP
02 / SANADA Mitsuaki
c/o Basic Research Center
Toray Industries Inc.
10-1
Tebiro 6-chome
Kamakura-shi Kanagawa 248-8555 / JP
03 / SASAJIMA Yoshiyuki
c/o Basic Research Center
Toray Industries Inc.
10-1
Tebiro 6-chome
Kamakura-shi Kanagawa 248-8555 / JP
04 / JUNG Giman
c/o Basic Research Center
Toray Industries Inc.
10-1
Tebiro 6-chome
Kamakura-shi Kanagawa 248-8555 / JP
05 / YAMADA Tesshi
c/o National Cancer Center
1-1
Tsukiji 5-chome
Chuo-ku
Tokyo 104-0045 / JP
06 / HONDA Kazufumi
c/o National Cancer Center
1-1
Tsukiji 5-chome
Chuo-ku
Tokyo 104-0045 / JP
 [2018/02]
Representative(s)Prüfer & Partner mbB Patentanwälte · Rechtsanwälte
Sohnckestraße 12
81479 München / DE
[2018/02]
Application number, filing date16758903.501.03.2016
[2018/02]
WO2016JP56190
Priority number, dateJP2015004058002.03.2015         Original published format: JP 2015040580
[2018/02]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016140210
Date:09.09.2016
Language:JA
[2016/36]
Type: A1 Application with search report 
No.:EP3267197
Date:10.01.2018
Language:EN
[2018/02]
Type: B1 Patent specification 
No.:EP3267197
Date:16.09.2020
Language:EN
[2020/38]
Search report(s)International search report - published on:JP09.09.2016
(Supplementary) European search report - dispatched on:EP04.03.2019
ClassificationIPC:G01N33/68, C07K14/775, C07K16/18, G01N33/53, G01N33/574
[2018/52]
CPC:
G01N33/57438 (EP,US); G01N33/6893 (US); C07K14/775 (EP,US);
C07K16/18 (EP,US); G01N2333/775 (EP,US); G01N2800/06 (US);
G01N2800/067 (EP,US) (-)
Former IPC [2018/02]G01N33/68, C07K14/775, C07K16/18, G01N33/53
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/02]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:PANKREASFEHLFUNKTIONSNACHWEISVERFAHREN UND NACHWEISKIT[2018/02]
English:METHOD AND KIT FOR THE DETECTION OF PANCREATIC DYSFUNCTION[2020/37]
French:PROCÉDÉ DE DÉTECTION DE DYSFONCTIONNEMENT PANCRÉATIQUE ET KIT DE DÉTECTION[2018/02]
Former [2018/02]PANCREATIC DYSFUNCTION DETECTION METHOD AND DETECTION KIT
Entry into regional phase19.09.2017Translation filed 
19.09.2017National basic fee paid 
19.09.2017Search fee paid 
19.09.2017Designation fee(s) paid 
19.09.2017Examination fee paid 
Examination procedure19.09.2017Examination requested  [2018/02]
19.09.2017Date on which the examining division has become responsible
20.09.2019Amendment by applicant (claims and/or description)
16.10.2019Despatch of a communication from the examining division (Time limit: M04)
24.02.2020Reply to a communication from the examining division
07.04.2020Communication of intention to grant the patent
05.08.2020Fee for grant paid
05.08.2020Fee for publishing/printing paid
05.08.2020Receipt of the translation of the claim(s)
Opposition(s)17.06.2021No opposition filed within time limit [2021/34]
Fees paidRenewal fee
28.02.2018Renewal fee patent year 03
30.01.2019Renewal fee patent year 04
27.03.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.03.2016
AL16.09.2020
AT16.09.2020
CY16.09.2020
CZ16.09.2020
EE16.09.2020
ES16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
MC16.09.2020
MK16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SI16.09.2020
SK16.09.2020
SM16.09.2020
TR16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
IE01.03.2021
LU01.03.2021
[2024/29]
Former [2024/22]HU01.03.2016
AL16.09.2020
AT16.09.2020
CY16.09.2020
CZ16.09.2020
EE16.09.2020
ES16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
MC16.09.2020
MK16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SI16.09.2020
SK16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
IE01.03.2021
LU01.03.2021
Former [2023/33]HU01.03.2016
AL16.09.2020
AT16.09.2020
CY16.09.2020
CZ16.09.2020
EE16.09.2020
ES16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
MC16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SI16.09.2020
SK16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
IE01.03.2021
LU01.03.2021
Former [2023/30]AL16.09.2020
AT16.09.2020
CY16.09.2020
CZ16.09.2020
EE16.09.2020
ES16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
MC16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SI16.09.2020
SK16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
IE01.03.2021
LU01.03.2021
Former [2022/09]AL16.09.2020
AT16.09.2020
CZ16.09.2020
EE16.09.2020
ES16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
MC16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SI16.09.2020
SK16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
IE01.03.2021
LU01.03.2021
Former [2022/07]AL16.09.2020
AT16.09.2020
CZ16.09.2020
EE16.09.2020
ES16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
MC16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SI16.09.2020
SK16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
IE01.03.2021
Former [2021/45]AL16.09.2020
AT16.09.2020
CZ16.09.2020
EE16.09.2020
ES16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
MC16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SI16.09.2020
SK16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
Former [2021/36]AL16.09.2020
AT16.09.2020
CZ16.09.2020
EE16.09.2020
ES16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SI16.09.2020
SK16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
Former [2021/28]AL16.09.2020
AT16.09.2020
CZ16.09.2020
EE16.09.2020
ES16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SK16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
Former [2021/25]AL16.09.2020
AT16.09.2020
CZ16.09.2020
EE16.09.2020
ES16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
Former [2021/23]AT16.09.2020
CZ16.09.2020
EE16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
RO16.09.2020
RS16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
PT18.01.2021
Former [2021/22]CZ16.09.2020
EE16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
RO16.09.2020
RS16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
PT18.01.2021
Former [2021/21]FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
RS16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
PT18.01.2021
Former [2021/20]FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
RS16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
Former [2021/10]FI16.09.2020
HR16.09.2020
LV16.09.2020
RS16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
Former [2021/08]FI16.09.2020
BG16.12.2020
NO16.12.2020
Former [2021/07]FI16.09.2020
NO16.12.2020
Documents cited:Search[A]  - BJÖRN LINDKVIST, "Diagnosis and treatment of pancreatic exocrine insufficiency", WORLD JOURNAL OF GASTROENTEROLOGY, CN, (20130101), vol. 19, no. 42, doi:10.3748/wjg.v19.i42.7258, ISSN 1007-9327, page 7258, XP055494205 [A] 1-11 * the whole document *

DOI:   http://dx.doi.org/10.3748/wjg.v19.i42.7258
 [T]  - MIROSLAV VUJASINOVIC ET AL, "Pancreatic Exocrine Insufficiency in Pancreatic Cancer", NUTRIENTS, (20170223), vol. 9, no. 3, doi:10.3390/nu9030183, page 183, XP055494207 [T] 1-11 * the whole document *

DOI:   http://dx.doi.org/10.3390/nu9030183
 [A]  - M. A. FRYIRS ET AL, "Effects of High-Density Lipoproteins on Pancreatic -Cell Insulin Secretion", ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY., US, (20100801), vol. 30, no. 8, doi:10.1161/ATVBAHA.110.207373, ISSN 1079-5642, pages 1642 - 1648, XP055494209 [A] 1-11 * the whole document *

DOI:   http://dx.doi.org/10.1161/ATVBAHA.110.207373
 [T]  - SHODA K ET AL, "Clinical utility of apolipoprotein-AII isoforms for pancreaticexocrine function", EMBASE, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (20180101), Database accession no. EMB-621975500, XP002783244 [T] 1-11 * abstract *
 [P]  - SHODA K ET AL, "Clinical utility of apolipoprotein-AII isoforms for pancreaticexocrine function", CANCER SCIENCE 20180101 BLACKWELL PUBLISHING LTD NLD, (20180101), vol. 109, no. Supplement 1, ISSN 1349-7006
International search[A]JP2008516965  (Altus Pharmaceuticals Inc.) [A] 1-13 * , paragraph [0005] & US 2006/0121017 A1 paragraph [0005] & WO 2006/044529 A1 & EP 2198880 A1 *;
 [A]JP2010533855  (Biomerieux) [A] 1-13 * , & US 2010/0130375 A1 & WO 2009/019370 A2 *;
 [PX]WO2015050107  (TORAY INDUSTRIES [JP], et al) [PX] 1-3, 8-13* , (Family: none) *;
 [XA]  - HONDA KAZUFUMI et al., "Altered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validation", PLOS ONE, vol. 7, no. 10, page e46908, XP055331189 [X] 1-3, 8-12 [A] 4-7, 13

DOI:   http://dx.doi.org/10.1371/journal.pone.0046908
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.